Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   HEPATITIS MONTHLY   FEBRUARY 2011 , Volume 11 , Number 2 (31); Page(s) 119 To 122.
 
Paper: 

EFFICACY OF HEPATITIS B VACCINE IN THOSE WHO LOST HEPATITIS B SURFACE ANTIGEN DURING FOLLOW-UP

 
 
Author(s):  TAHERI HASAN, HASANJANI ROUSHAN M.R.*, SOLEYMANI AMIRI M.J., POURALIJAN M., BIJANI A.
 
* INFECTIOUS DISEASES RESEARCH CENTER, BABOL UNIVERSITY OF MEDICAL SCIENCES, BABOL, IR IRAN
 
Abstract: 

Background: The level of HBsAg in some chronic hepatitis B virus (HBV)-infected individuals may decline over time so that it is not detectable in serum.
Objective: To assess the efficacy of HBV vaccine in those who lost their HBsAg without seroconverssion to anti-HBs antibody.
Patients and Methods: From April 1993 to December 2008, of 1603 chronic HBV-infected individuals, 34 (22 men and 12 women) became HBsAg-negative in follow-up visits, with no detectable anti-HBs antibody and HBV DNA in their sera. They received HBV vaccination at 0, 1 and 6 months (case group). Fifty-two subjects (30 men and 22 women) who were negative for HBsAg, anti-HBs and anti-HBc antibody, received HBV vaccination according to the said schedule (control group). Anti-HBs antibody was assessed one month after the last dose of vaccination in the both groups.
Results: The mean±SD age of the case and control groups was 38
±12.7 and 33.4±8.6 years, respectively (p=0.07). The sex distribution between these two groups were similar (p=0.652). The mean±SD years of follow-up for the case group were 7.6±4.5 years. Anti-HBs antibody level ³10 IU/L was found in 8 (24%) subjects in the case group and in 45 (87%) in the control group (p<0.001). The mean±SD anti-HBs antibody level in the case group was 68±32.66 and in the control group 344.6±38.9 IU/L (p<0.001).
Conclusions: We found that nearly 24% of chronic HBsAg-positive subjects who lost their HBsAg responded to HBV and the remaining cases need to be followed for occult HBV infection.

 
Keyword(s): CHRONIC HEPATITIS B, FOLLOW-UP STUDY, HBSAG, HEPATITIS B VIRUS, HEPATITIS B VACCINE
 
References: 
  • ندارد
 
  pdf-File tarjomyar Yearly Visit 100
 
Latest on Blog
Enter SID Blog